VertiMobile

Diagnostic system using video technology to record and analyze eye movements and nystagmus for vestibular and neurological assessment.

Advanced diagnostic systems utilizing videonystagmography (VNG) and sophisticated vestibular testing solutions to provide accurate and rapid diagnosis of vertigo and balance disorders.

Advanced eye-movement tracking and analysis system for detecting nystagmus and assessing vestibular function during diagnostic testing. Provides real-time video recording and quantitative analysis of ocular movements to support accurate vestibular disorder diagnosis.

NeuroSwift® is an advanced eye movement data collection system integrated with videonystagmoscope technology for neuro-otological and ophthalmological diagnostics. The device captures and analyzes ocular movements to assess vestibular function, neurological disorders, and balance-related conditions. It enables comprehensive evaluation of nystagmus, saccades, and pursuit movements for clinical diagnosis and patient monitoring.

NeuroSwift® Pro is an advanced eye tracking system for vestibular and neurological diagnosis. It provides precise oculomotor measurements to support clinical assessment of balance disorders, vertigo, and neurological conditions. The device integrates comprehensive neuro-otological and ophthalmological diagnostic capabilities for efficient patient evaluation.

BioMed’s vestibular diagnostic solution, centered on the COMBI MASK, seamlessly integrates VNG, VHIT, Frenzel, SVV, Posturography, and Air Irrigator into a single platform, delivering an innovative system of automation, precision, and convenience that enhances efficiency for clinicians while providing patients with trust and reassurance in a truly all-in-one diagnostic environment.

A medical device for video Frenzel testing and ocular motility control. The system enables oculomotor assessment and vertigo differentiation through eye movement analysis. It supports myopia management and risk prediction applications for clinical use in checkup centers and healthcare provider settings.

eVNG USB is a video nystagmography system for detecting and analyzing eye movement disorders related to vestibular and neurological conditions. The device captures high-speed infrared eye tracking to diagnose nystagmus, vertigo, and balance disorders in clinical and research settings. USB connectivity enables seamless integration with diagnostic workstations for real-time analysis and documentation.

Specialized diagnostic devices for balance and vestibular system assessment in patients with dizziness or equilibrium disorders. These systems measure vestibular function through standardized protocols.

South Korea's first VR-based dizziness diagnostic software that performs VOR tests, oculomotor tests, and SVV/SVH tests through a single VR platform using HMD eye-tracking technology. It provides VNG testing equivalent to conventional electronystagmography devices with a compact size and intuitive interface. The software holds Korean regulatory approval as a grade 2 balance function analysis software (approval No. 제인 22-4263호, E03040.01), FDA 510(k) approval (K243709), and EN ISO13485 certification, with planned addition of vHIT test modules by June 2026.

A portable, CE-marked class IIa medical device designed for clinical eye movement recording and analysis. The system uses two infrared cameras recording at 400 fps to capture eye movements without patient calibration. Proprietary AI algorithms compute objective biomarkers displayed alongside reference ranges to support differential diagnosis of neurological disorders, particularly atypical parkinsonian syndromes and cerebellar dysfunction. The examination takes approximately 10 minutes and results can be interpreted with eye movement timecourses and video recordings.

Vertigo Diagnosis and Treatment System is a specialized diagnostic device for evaluating vestibular disorders and balance dysfunction. It combines diagnostic testing with therapeutic protocols for patients experiencing dizziness and vertigo. The system supports clinicians in identifying underlying causes and monitoring treatment response through structured assessment protocols.